Related information
by Kling, H.M. et al.Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.J. Acquir. Immune Defic....
View ArticleRelated information
by Abdulhamid, I. et al.Hepatotoxicity induced by trimethoprim-sulfamethoxazole in a child with cystic fibrosis.J. Pediatr. Pharmacol. Ther. 2014; 1:56-9[See paper]
View ArticleRelated information
by Shulgina, L. et al.Norwich Medical School, University of East Anglia, Norwich, UKThe addition of co-trimoxazole therapy to standard treatment for fibrotic idiopathic interstitial pneumonia had no...
View ArticleRelated information
by Forde, D.G. et al.Department of Infection and Tropical Medicine, Sheffield Teaching Hospital, Sheffield, UKHypoglycaemia associated with co-trimoxazole use in a 56-year-old Caucasian woman with...
View ArticleRelated information
by Lee, K.Y. et al.Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan In multivariate logistic regression analysis,...
View ArticleRelated information
by Hobbs, C.V. et al.NIH/NIAID/Laboratory of Malaria Immunology and Vaccinology, Rockville, Maryland NNRTIs modestly affect liver stage Plasmodium parasites, whereas TMP-SMX prevents patent...
View ArticleRelated information
by Zhang, C.C. et al.Division of Infectious Diseases, Department of Internal Medicine, Chi Mei Medical Center, Tainan, TaiwanBrevundimonas vesicularis bacteremia resistant to...
View ArticleRelated information
by Soeters, H.M. et al.Address correspondence to Heidi M. Soeters TMP-SMX nonsusceptibility was associated with nonsusceptibility to penicillin, erythromycin, and rifampin and multidrug...
View ArticleRelated information
by Stuck, A.K. et al.Address correspondence to Kathrin MühlemannDeterminants of Quinolone versus Trimethoprim-Sulfamethoxazole Use for Outpatient Urinary Tract Infection.Antimicrob. Agents Chemother....
View ArticleRelated information
by Kamath, S. et al.Department of Ophthalmology, St John's Medical College, Bangalore, India This case report highlights the occurrence of ocular adverse drug reactions (ADRs) in HIV-infected patients...
View ArticleRelated information
by Mirzabeigi, M.N. et al.Division of Plastic Surgery, University of Pennsylvania Health System, Philadelphia, Pa 19104, USA The mean time to infection was 13 weeks for the routine cephalosporin group...
View ArticleRelated information
by Pham, B.N. et al.From the Institut National de la Transfusion Sanguine, CNRGS-INSERM U665, Paris; and Etablissement Français du Sang, Ile de France, FranceAntibodies to co-trimoxazole (trimethoprim...
View ArticleRelated information
by Fraser, T.N. et al.Medical Care Line (Infectious Disease Section), Michael E. DeBakey Veterans Affairs Medical Center and the Departments of Medicine and Molecular Virology and Microbiology, Baylor...
View ArticleRelated information
by Messina, A.F. et al.From the Departments of *Pediatrics Division of Infectious Diseases and †Pharmacy, All Children's Hospital/Johns Hopkins Medicine, Saint Petersburg, FL: Orally administered...
View ArticleRelated information
by Hutchinson, E. et al.Department of Global Health and Development, London School of Hygiene and Tropical Medicine, 15–17 Tavistock Place, London, EnglandTranslating evidence into policy in...
View ArticleRelated information
by Everett, D.B. et al.Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, Chichiri, Blantyre, MalawiThe introduction of cotrimoxazole prophylaxis in HIV-infected groups...
View ArticleRelated information
by Acuña, M. et al.Nephrology, IIS-Fundacion Jimenez Diaz and Autonoma University of de Madrid, Madrid, SpainCotrimoxazole acute interstitial nephritis is an infrequent but treatable cause of kidney...
View ArticleRelated information
by Barton, E. et al.Department of Microbiology, North Bristol NHS Trust, Southmead Hospital, Bristol, UKNo significant change in renal function, evaluated by serum creatinine, was observed during...
View ArticleRelated information
by Date, A.A. et al.Global AIDS Program, Centers for Disease Control and Prevention, Atlanta, GA, United States of AmericaImplementation of co-trimoxazole prophylaxis and isoniazid preventive therapy...
View ArticleRelated information
by Scourfield, A. et al.Department of HIV Medicine, Chelsea and Westminster Hospital, London, UKSevere septic-shock like reaction to co-trimoxazole in an HIV-positive man.Int. J. STD. AIDS. 2010;...
View ArticleRelated information
by Hanses, F. et al.Department of Internal Medicine I, University Hospital, University of Regensburg, 93042 Regensburg, GermanyWe report two cases of severely immunocompromised HIV-infected patients...
View ArticleRelated information
by Zycinska, K. et al.Primary Systemic Vasculitis Outpatient Clinic, Department of Family Medicine, Internal and Metabolic Diseases, Warsaw Medical University, PolandTreatment with co-trimoxazole...
View ArticleRelated information
by Béraud, G. et al.Infectious Diseases Department Comité de Coordination de la Lutte Contre le Virus de l'Immunodéficience Humaine de la Martinique, Centre d'Investigation Clinique-Epidémiologique...
View ArticleRelated information
by Shewiyo, D.H. et al.Directorate of Laboratory Services, Tanzania Food and Drugs Authority, P.O. Box 77150, Dar es Salaam, TanzaniaDevelopment and validation of a normal-phase high-performance thin...
View ArticleRelated information
by Patriarca, G. et al.Department of Allergology, Università Cattolica del Sacro Cuore, ItalyWe suggest that desensitization protocols with co-trimoxazole be considered in patients with fixed drug...
View ArticleRelated information
by Nunn, A.J. et al.Medical Research Council Clinical Trials Unit, London NW1 2DAProphylaxis with co-trimoxazole reduces mortality in HIV infected adults with pulmonary tuberculosis.BMJ. 2008;...
View ArticleRelated information
by Varney, V.A. et al.Department of Respiratory Medicine, St Helier Hospital, Wrythe Lane, Carshalton, UKA double blind randomised placebo controlled pilot study of oral co-trimoxazole in advanced...
View ArticleRelated information
by Gill, C.J. et al.Department of International Health, Boston University School of Public Health, Boston, MA, United States of AmericaCo-trimoxazole prophylaxis modestly suppresses pneumococcal...
View ArticleRelated information
by Miah, M.A. et al.Department of Dermatology and Venereology, Mymensingh Medical College & Hospital, Mymensingh, BangladeshFixed drug eruptions due to cotrimoxazole.Mymensingh. Med. J. 2008; 2...
View ArticleRelated information
by Falagas, M.E. et al.Alfa Institute of Biomedical Sciences, Athens, GreeceThe limited available data suggest that ciprofloxacin, ceftazidime or ceftriaxone, and ticarcillin/clavulanate, alone or in...
View ArticleRelated information
by Sivalingam, S.P. et al.Defence Medical and Environmental Research Institute, DSO, National Laboratories, 27 Medical Drive, SingaporeAnimals receiving amoxicillin/clavulanic acid as pre-exposure...
View ArticleRelated information
by Lin, D. et al.In the small trials included in this review, when compared to cotrimoxazole rechallenge for prophylaxis of opportunistic infections, cotrimoxazole desensitization resulted in fewer...
View ArticleRelated information
by Soejima, M. et al.Institute of Rheumatology, Tokyo Women's Medical University School of Medicine, Kawada-cho, Shinjuku-ku, JapanAssociation of the diplotype configuration at the N-acetyltransferase...
View ArticleRelated information
by Arens, J. et al.Division of Clinical Pharmacology, University of Cape TownTreating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome...
View Article25 words added, 3 annot. added
by Mulenga, V. et al.Text changed: The largest excess of hospital deaths in the placebo group was from respiratory infections [22/56 (39%) placebo versus 10/35 (29%) cotrimoxazole] [Ref]. [See latest...
View ArticleRelated information
by Schalekamp, T. et al.Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, NetherlandsAvoidance of...
View ArticleRelated information
by Grimwade, K. et al.It studied 534 children with HIV infection in Lusaka, Zambia. The study was conducted in an area of high bacterial resistance to cotrimoxazole (60-80%).Cochrane. Database. Syst....
View ArticleRelated information
by Miller, L.G. et al.A total of 524 patients were enrolled (264 in the clindamycin group and 260 in the TMP-SMX group), including 155 children (29.6%).N. Engl. J. Med. 2015; 12:1093-103[See paper]
View ArticleRelated information
by Paul, M. et al. No significant difference in treatment failure was seen for trimethoprim-sulfamethoxazole (51/135, 38%) versus vancomycin (32/117, 27%)-risk ratio 1.38 (95% confidence interval 0.96...
View ArticleRelated information
by Menger, R.P. et al. Aplastic anemia is a rare complication of the administration of trimethoprim-sulfamethoxazole.Case. Rep. Hematol. 2015; 374951[See paper]
View ArticleRelated information
by Bowen, A.C. et al.Short-course co-trimoxazole is a non-inferior, alternative treatment to benzathine benzylpenicillin for impetigo; it is palatable, pain-free, practical, and easily...
View ArticleRelated information
by Kamuhabwa, A.A. et al.Most children who were initiated with co-trimoxazole prophylaxis did not experience significant opportunistic infections, and the drug was well tolerated.Drug. Healthc....
View ArticleRelated information
by Choudhury, H. et al.The role of intravitreal trimethoprim/sulfamethoxazole in the treatment of toxoplasma retinochoroiditis.Ophthalmic. Surg. Lasers. Imaging. Retina. 2015; 1:137-40[See paper]
View ArticleRelated information
by Huntsberry, A.M. et al.Our patient developed hyponatremia from TMP-SMX therapy upon initial use and rechallenge.Clin. Interv. Aging. 2015; 1091-6[See paper]
View ArticleRelated information
by Rijal, J.P. et al.A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole.BMJ. Case. Rep. 2014; [See paper]
View ArticleRelated information
by Teker, D. et al. Anti-brucellosis treatment regimens include doxycycline for children older than eight years old and rifampicin and trimethoprim/sulfamethoxazole (TMP-SMX) combination therapy for...
View ArticleRelated information
by Homsy, J. et al.Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label...
View Article
